Zhang, Ling-Yun <br/><br/>
Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism.  [electronic resource] 

 -  Saudi medical journal  Nov 2018 
 - 1090-1095 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1658-3175 
<br/><br/><label>Standard No.: </label>10.15537/smj.2018.11.22717  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aged<br/>Anticoagulants--therapeutic use<br/>Arterial Pressure--drug effects<br/>Female<br/>Fibrinolytic Agents--therapeutic use<br/>Heparin, Low-Molecular-Weight--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Pulmonary Artery<br/>Pulmonary Embolism--drug therapy<br/>Recombinant Proteins--therapeutic use<br/>Systole<br/>Tissue Plasminogen Activator--therapeutic use